Pfizer: Respiratory Syncytial Virus Infections trials

The registry lists 13 Respiratory Syncytial Virus Infections studies with Pfizer as lead sponsor. 2 are open to participants now and 4 have results posted.

Phase 1 6Phase 2 3Phase 3 3No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National DatasetNot yet recruitingNCT07235397
• A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single DoseRecruitingNCT06866405Phase 3
• A Study to Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Adults.CompletedNCT06473519Phase 3Results posted
• A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSVTerminatedNCT06102174Phase 1Results posted
• A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) InfectionTerminatedNCT06079320Phase 2/3Results posted
• A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.CompletedNCT05987072Phase 1Results posted
• SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDERActive, not recruitingNCT06546800
• Safety, Tolerability, Pharmacokinetics, and Food Effect Study of RV299 in Healthy AdultsCompletedNCT06033612Phase 1
• A Study to Learn About Effect of Sisunatovir in Healthy Adult Male ParticipantsCompletedNCT05873764Phase 1
• Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSVWithdrawnNCT04267822Phase 2
• Pharmacokinetics and Safety of RV521 FormulationsCompletedNCT04065698Phase 1
• A Study to Learn About the Drug-drug Interactions of Sisunatovir in Healthy Adult ParticipantsCompletedNCT03782662Phase 1
• A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) InfectionCompletedNCT03258502Phase 2